Search results

Order by most recent / most popular / relevance

Results: 11-20 of 438

Recusal issue arises in US Supreme Court's consideration of Wyeth v Levine drug labeling preemption case

Edwards Wildman Palmer LLP
-
USA
-
February 18 2009

As previously reported here, the U.S. Supreme Court heard oral arguments in Wyeth v. Levine on November 3, 2008

Third Circuit vacates dismissal of Celebrex securities fraud class action

Edwards Wildman Palmer LLP
-
USA
-
February 17 2009

The United States Court of Appeals for the Third Circuit (“Third Circuit”) recently vacated the dismissal of a securities fraud class action alleging that a pharmaceutical company, Pharmacia, Inc., made materially false statements about a clinical study of a popular anti-inflammatory medication

U.S. health insurance costs subsidize the uninsured

Edwards Wildman Palmer LLP
-
USA
-
June 2 2009

A recent report by Families USA, an advocacy group, said that the average family pays $1,000 a year more for health insurance premiums to subsidize the cost of health care for the uninsured

COBRA premium subsidy included in American Recovery and Reinvestment Act of 2009

Edwards Wildman Palmer LLP
-
USA
-
June 1 2009

Recognizing that few laid-off employees can afford to continue health coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA), laid-off employees will now be eligible for a temporary reduction in their COBRA premiums under the American Recovery and Reinvestment Act of 2009 (the "Act"

AHA to Senate: don't cut Medicare payments

Edwards Wildman Palmer LLP
-
USA
-
June 2 2009

The American Hospital Association last week submitted a comment letter to the Senate Finance Committee urging the Committee not to reduce hospitals’ Medicare payments to help fund health care reform

Federal District Court rules that FDA regulations do not preempt state law claims, allows state failure-to-warn claims against pharmaceutical company to proceed

Edwards Wildman Palmer LLP
-
USA
-
August 15 2007

The Federal District Court for the Eastern District of Louisiana recently held that state failure-to-warn claims are not preempted by the labeling requirements of the Food and Drug Administration

Medical malpractice premiums to increase in New York

Edwards Wildman Palmer LLP
-
USA
-
August 6 2007

On July 2, 2007, New York State Insurance Superintendent Eric R. Dinallo announced that the Department approved a 14 increase in medical malpractice insurance rates

Important national health care reform bills awaiting action by Congress

Edwards Wildman Palmer LLP
-
USA
-
August 14 2007

On January 17, 2007, lawmakers in the House and Senate introduced identical bills (H.R. 506 and S. 325) aimed at funding innovative State initiatives that expand coverage and access to the uninsured and improve quality and efficiency in the health care system

DC Circuit: no constitutional right for terminal patients to receive experimental drugs

Edwards Wildman Palmer LLP
-
USA
-
August 15 2007

In an 8-2 en banc ruling, the D.C. Court of Appeals has held that terminally ill patients do not have a constitutional due process right to access experimental drugs

Massachusetts mandatory health insurance

Edwards Wildman Palmer LLP
-
USA
-
August 8 2007

On April 12, 2006, Massachusetts Governor Mitt Romney signed a health care bill, known as "An Act Providing Access to Affordable, Quality, Accountable Health Care (the "Act")", into law

< back next >

Search results

Recusal issue arises in US Supreme Court's consideration of Wyeth v Levine drug labeling preemption case

Third Circuit vacates dismissal of Celebrex securities fraud class action

U.S. health insurance costs subsidize the uninsured

COBRA premium subsidy included in American Recovery and Reinvestment Act of 2009

AHA to Senate: don't cut Medicare payments

Federal District Court rules that FDA regulations do not preempt state law claims, allows state failure-to-warn claims against pharmaceutical company to proceed

Medical malpractice premiums to increase in New York

Important national health care reform bills awaiting action by Congress

DC Circuit: no constitutional right for terminal patients to receive experimental drugs

Massachusetts mandatory health insurance

Current Search

Suggested Facets

Author

Jurisdiction

Workarea